De Beer F C, Shine B, Pepys M B
Clin Exp Immunol. 1982 Oct;50(1):231-7.
A radiometric ligand binding assay for human C-reactive protein (CRP) was established using pneumococcal C polysaccharide (CPS) coupled to magnetizable cellulose particles as the solid phase ligand. Competition for binding to the solid phase between 125I-CRP and unlabelled CRP permitted detection of 30 micrograms/l of CRP and the precise assay of concentrations up to 3000 micrograms/l. Identical results were obtained when the assay was used to quantitate isolated pure CRP and pure CRP added to normal human serum. However in vitro addition of known ligands for CRP to acute phase serum resulted in lowering of the apparent CRP concentration in this assay and addition of as little as 1 microgram/l of free CPS or 1 mg/l of lecithin was demonstrable in this way. A combination of the ligand binding assay and the standard electroimmunoassay for CRP was therefore used to test acute phase sera for the presence of CRP complexed in vitro. No evidence of complexed CRP was detected among sera containing between 1-319 mg/l of CRP from patients with Hodgkin's disease (10), rheumatoid arthritis (10), Crohn's disease (19) and various microbial infections (11), including six with subacute bacterial endocarditis. Since it is likely that CRP does form complexes with its ligands in the plasma these results suggest that complexed CRP is rapidly cleared from the circulation.
利用与可磁化纤维素颗粒偶联的肺炎球菌C多糖(CPS)作为固相配体,建立了一种用于检测人C反应蛋白(CRP)的放射性配体结合测定法。125I-CRP与未标记的CRP竞争与固相的结合,从而能够检测到30微克/升的CRP,并精确测定高达3000微克/升的浓度。当该测定法用于定量分离的纯CRP以及添加到正常人血清中的纯CRP时,获得了相同的结果。然而,在急性期血清中体外添加已知的CRP配体,会导致该测定法中表观CRP浓度降低,并且以此方式可证明添加低至1微克/升的游离CPS或1毫克/升的卵磷脂也会有此效果。因此,将配体结合测定法与CRP的标准电免疫测定法相结合,用于检测急性期血清中体外复合CRP的存在情况。在患有霍奇金病(10例)、类风湿性关节炎(10例)、克罗恩病(19例)和各种微生物感染(11例)(包括6例亚急性细菌性心内膜炎患者)的患者的血清中,未检测到复合CRP的证据,这些患者的血清CRP含量在1 - 319毫克/升之间。由于CRP很可能在血浆中确实与其配体形成复合物,这些结果表明复合CRP会迅速从循环中清除。